ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification

Journal of Diabetes and its Complications

Volumn 21, Issue 5, 2007, Pages 273-279

  Maahs, David M ^a   Snell Bergeon, Janet K ^b   Kinney, Gregory L ^b   Wadwa, R Paul ^a   Garg, Satish ^a   Ogden, Lorraine G ^b   Rewers, Marian ^a,b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

ACE I ARB treatment; Albuminuria; Coronary artery disease; Epidemiology; Type 1 diabetes

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ALBUMINURIA; ARTERY CALCIFICATION; ARTICLE; CORONARY ARTERY; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL;

ADULT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCINOSIS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 2; REGRESSION ANALYSIS;

EID: 34548312275     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.04.004     Document Type: Article

References (26)

1. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology 15 (1990) 827-832
2. Asselbergs F.W., Diercks G.F., Hillege H.L., van Boven A.J., Janssen W.M., Voors A.A., de Zeeuw D., De Jong P.E., van Veldhuisen D.J., and van Gilst W.H. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110 (2004) 2809-2816
3. Barnett A.H., Bain S.C., Bouter P., Karlberg B., Madsbad S., Jervell J., and Mustonen J. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. New England Journal of Medicine 351 (2004) 1952-1961
4. Callister T.Q., Cooil B., Raya S.P., Lippolis N.J., Russo D.J., and Raggi P. Coronary artery disease: Improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 208 (1998) 807-814
5. Dabelea D., Kinney G., Snell-Bergeon J.K., Hokanson J.E., Eckel R.H., Ehrlich J., Garg S., Hamman R.F., and Rewers M. Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 52 (2003) 2833-2839
6. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., and Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. [see comments]. Diabetologia 32 (1989) 219-226
7. de Zeeuw D., Remuzzi G., Parving H.H., Keane W.F., Zhang Z., Shahinfar S., Snapinn S., Cooper M.E., Mitch W.E., and Brenner B.M. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110 (2004) 921-927
8. Forrest K.Y., Becker D.J., Kuller L.H., Wolfson S.K., and Orchard T.J. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148 (2000) 159-169
9. Gerstein H.C., Mann J.F., Pogue J., Dinneen S.F., Halle J.P., Hoogwerf B., Joyce C., Rashkow A., Young J., Zinman B., and Yusuf S. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 23 Suppl 2 (2000) B35-B39
10. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., Halle J.P., Young J., Rashkow A., Joyce C., Nawaz S., and Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Journal of the American Medical Association 286 (2001) 421-426
11. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176
12. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355 (2000) 253-259
13. Hillege H.L., Fidler V., Diercks G.F., van Gilst W.H., de Zeeuw D., van Veldhuisen D.J., Gans R.O., Janssen W.M., Grobbee D.E., and De Jong P.E. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
14. Hokanson J.E., Mackenzie T., Kinney G., Snell-Bergeon J.K., Dabelea D., Ehrlich J., Eckel R.H., and Rewers M. Evaluating changes in coronary artery calcium: An analytic method that accounts for interscan variability. American Journal of Roentgenology 182 (2004) 1327-1332
15. Kondos G.T., Hoff J.A., Sevrukov A., Daviglus M.L., Garside D.B., Devries S.S., Chomka E.V., and Liu K. Electron-beam tomography coronary artery calcium and cardiac events-A 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107 (2003) 2571-2576
16. Lopez-Sendon J., Swedberg K., McMurray J., Tamargo J., Maggioni A.P., Dargie H., Tendera M., Waagstein F., Kjekshus J., Lechat P., and Torp-Pedersen C. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-Inhibitors of the European Society of Cardiology. European Heart Journal 25 (2004) 1454-1470
17. Maahs D.M., Kinney G.L., Wadwa P., Snell-Bergeon J.K., Dabelea D., Hokanson J., Ehrlich J., Garg S., Eckel R.H., and Rewers M.J. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 28 (2005) 301-306
18. Maahs D.M., Ogden L.G., Kinney G.L., Wadwa P., Snell-Bergeon J.K., Dabelea D., Hokanson J.E., Ehrlich J., Eckel R.H., and Rewers M. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111 (2005) 747-753
19. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Annals of Internal Medicine 134 (2001) 629-636
20. Molitch M.E., DeFronzo R.A., Franz M.J., Keane W.F., Mogensen C.E., and Parving H.H. Diabetic nephropathy. Diabetes Care 26 Suppl 1 (2003) S94-S98
21. Rossing P., Hougaard P., Borch-Johnsen K., and Parving H.H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. British Medical Journal 313 (1996) 779-784
22. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., and Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92 (1995) 2157-2162
23. Shaw L.J., Raggi P., Schisterman E., Berman D.S., and Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology (2003)
24. Soedamah-Muthu S.S., Chaturvedi N., Toeller M., Ferriss B., Reboldi P., Michel G., Manes C., and Fuller J.H. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: The EURODIAB Prospective Complications Study. Diabetes Care 27 (2004) 530-537
25. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine 157 (1997) 2413-2446
26. Yuyun M.F., Khaw K.T., Luben R., Welch A., Bingham S., Day N.E., and Wareham N.J. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. International Journal of Epidemiology 33 (2004) 189-198